Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children

被引：5

作者：

Ross, Rachael K. ^{[1
]}

Keele, Luke ^{[2
]}

Kubis, Sherri ^{[3
]}

Lautz, Andrew J. ^{[4
]}

Dziorny, Adam C. ^{[5
]}

Denson, Adam R. ^{[5
]}

O'Connor, Kathleen A. ^{[5
]}

Chilutti, Marianne R. ^{[6
]}

Weiss, Scott L. ^{[5
]}

Gerber, Jeffrey S. ^{[1
,7
]}

机构：

[1] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Infect Dis,Dept Pediat, Philadelphia, PA 19104 USA

[2] Georgetown Univ, McCourt Sch Publ Policy, Washington, DC USA

[3] Childrens Hosp Philadelphia, Dept Nursing Resp Care & Neurodiagnost Serv, Philadelphia, PA 19104 USA

[4] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Crit Care Med, Cincinnati, OH 45229 USA

[5] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Crit Care Med,Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA

[6] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA

[7] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Gen Pediat,Dept Pediat, Philadelphia, PA 19104 USA

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2018年 / 7卷 / 02期

关键词：

antibiotics; critical care; pediatric; procalcitonin; RANDOMIZED CONTROLLED-TRIAL; BIAS REDUCTION; MULTICENTER; SEPSIS; SENSITIVITY; INFECTIONS; THERAPY; IMPACT;

D O I：

10.1093/jpids/piy004

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We retrospectively studied the effect of introducing procalcitonin into clinical practice on antibiotic use within a large academic pediatric intensive care unit. In the absence of a standardized algorithm, availability of the procalcitonin assay did not reduce the frequency of antibiotic initiations or the continuation of antibiotics for greater than 72 hours.

引用

页码：E43 / E46

页数：4

共 50 条

[41] Antibiotic coated central venous catheters in critically ill children
Immergluck, LH
Hayani, KC
Starosta, D
Schwartz, A
Kecskes, S
PEDIATRIC RESEARCH, 2003, 53 (04) : 324A - 324A
[42] INTRAVENOUS IMMUNOGLOBULIN USE IN CRITICALLY ILL CHILDREN
Jutras, Camille
Robitaille, Nancy
Sauthier, Michael
Du Pont-Thibodeau, Genevieve
Lacroix, Jacques
Trottier, Helen
Zarynchansky, Ryan
Tucci, Marisa
CLINICAL AND INVESTIGATIVE MEDICINE, 2021, 44 (03): : E11 - E18
[43] The use of haloperidol in agitated critically ill children
Harrison, AM
Lugo, RA
Lee, WE
Appachi, E
Bourdakos, D
Davis, SJ
McHugh, MJ
Weise, KL
CLINICAL PEDIATRICS, 2002, 41 (01) : 51 - 54
[44] The utility of procalcitonin in critically ill trauma patients
Sakran, Joseph V.
Michetti, Christopher P.
Sheridan, Michael J.
Richmond, Robyn
Waked, Tarek
Aldaghlas, Tayseer
Rizzo, Anne
Griffen, Margaret
Fakhry, Samir M.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 73 (02): : 413 - 418
[45] Procalcitonin as a marker of infection in critically ill patients
P Koukiasa
B Soulountsi
P Giallouris
A Vavlitou
M Filipescu
I Rodini
E Projia
M Bitzani
Critical Care, 8 (Suppl 1):
[46] INTRAVENOUS IMMUNOGLOBULIN USE IN CRITICALLY ILL CHILDREN
Jutras, Camille
Du Pont-Thibodeau, Genevieve
Lacroix, Jacques
Sauthier, Michael
Robitaille, Nancy
Tucci, Marisa
CRITICAL CARE MEDICINE, 2020, 48
[47] The many facets of procalcitonin in the critically ill population
Japiassu, Andre Miguel
Bozza, Fernando A.
CRITICAL CARE MEDICINE, 2012, 40 (10) : 2903 - 2905
[48] Procalcitonin: Is This the Promised Biomarker for Critically Ill Patients?
Fontela, Patricia S.
Lacroix, Jacques
JOURNAL OF PEDIATRIC INTENSIVE CARE, 2016, 5 (04) : 162 - 171
[49] A Practical Approach to Antibiotic Use in Critically Ill Obstetric Patients
Pacheco, Luis D.
Saad, Antonio F.
Saade, George R.
OBSTETRICS AND GYNECOLOGY, 2021, 138 (03): : 459 - 465
[50] Procalcitonin Serum Levels: Only a Useful Variable or a Must to Start Antibiotic Therapy in the Critically Ill? reply
Damas, Pierre
Layios, Nathalie
CRITICAL CARE MEDICINE, 2013, 41 (02) : E19 - E19

← 1 2 3 4 5 →